The latest announcements from JelikaLite, a medical technology company with focus on pediatric neurological health using non-invasive novel therapies.

JelikaLite presents results of the pivotal clinical trial at Rutgers University Center for Autism Research, Education, and Services (RUCARES)

JelikaLite presents results of the pivotal clinical trial at American Academy of Child & Adolescent Psychiatry.

After receiving the largest batch of applications in the competition’s history, Upstate Medical University’s CNY Biotech Accelerator (CNYBAC) has selected its 2021 Medical Device Innovation Challenge (MDIC) cohort – JelikaLite was one of the 6 selected teams.

Katya Sverdlov (CEO of JelikaLite) spoke with NYS Manufacturing Now about the company’s efforts to light the way to a brighter future.

Brain Scientific Announces Collaboration with JelikaLite in New Clinical Trial.